Clinical Study of Recombinant Novel Coronavirus Vaccine
Condition: Coronavirus Interventions: Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group; Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group; Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials